Vaxcyte Inc (PCVX)
88.54
+0.15
(+0.17%)
USD |
NASDAQ |
Nov 22, 16:00
89.00
+0.46
(+0.52%)
After-Hours: 20:00
Vaxcyte Total Assets (Quarterly): 3.560B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.560B |
| June 30, 2024 | 2.087B |
| March 31, 2024 | 2.091B |
| December 31, 2023 | 1.408B |
| September 30, 2023 | 1.496B |
| June 30, 2023 | 1.503B |
| March 31, 2023 | 1.008B |
| December 31, 2022 | 1.006B |
| September 30, 2022 | 412.06M |
| June 30, 2022 | 411.62M |
| Date | Value |
|---|---|
| March 31, 2022 | 402.72M |
| December 31, 2021 | 324.34M |
| September 30, 2021 | 354.07M |
| June 30, 2021 | 358.05M |
| March 31, 2021 | 382.35M |
| December 31, 2020 | 392.83M |
| September 30, 2020 | 403.82M |
| June 30, 2020 | 416.25M |
| March 31, 2020 | 162.53M |
| December 31, 2019 | 65.70M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
65.70M
Minimum
Dec 2019
3.560B
Maximum
Sep 2024
912.29M
Average
411.84M
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc | 219.48B |
| Merck & Co Inc | 117.53B |
| Embecta Corp | 1.268B |
| Arrowhead Pharmaceuticals Inc | 883.76M |
| Dyne Therapeutics Inc | 768.84M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 142.11M |
| Shareholders Equity (Quarterly) | 3.418B |